secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2024-10-18T23:59:59+00:00
Accession:  0001654954-24-013107
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Zivo Bioscience sells 169,022 unregistered shares at avg $10.44 to accredited investors
--------------------------------------------------------------------------------

- Sold 169,022 shares between Aug 22 and Oct 17, 2024, at $8.34 to $16.31 per share (avg $10.44).
- Of total, 52,802 shares sold to related parties at avg $9.68 per share.
- No solicitation or underwriting discounts; exempt under Section 4(a)(2) and Regulation D.
- As of Oct 17, 2024, outstanding shares total 3,535,134 (dilution ~4.8% from offering).
- Proceeds used for general corporate purposes (not stated, typical for such offerings).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424013107/0001654954-24-013107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495424013107/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-013107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer